HIT Consultant Media’s Post

🎗️ Colorectal Cancer Awareness Month! 🎗️ Colorectal cancer (CRC) ranks as the third most prevalent cancer globally, yet it's also among the most preventable and treatable when detected early. Despite its stealthy nature in the early stages, recognizing potential warning signs is crucial for timely intervention. As we commemorate Colorectal Cancer Awareness Month, let's deepen our understanding of this formidable disease and familiarize ourselves with its potential warning signs. Join us in spreading the word to raise awareness. Together, we can make a difference in the fight against colorectal cancer. #ColorectalCancerAwareness #EarlyDetection #SpreadAwareness #HealthAwareness #FightCRC

Explore challenges of lung cancer prevention in this infographic series - ASPIRE for Lung Cancer OncoDaily #LungCancer #Cancer #OncoDaily #Oncology

🎗️ Colorectal Cancer Awareness Month! 🎗️ Colorectal cancer (CRC) ranks as the third most prevalent cancer globally, yet it's also among the most preventable and treatable when detected early. Despite its stealthy nature in the early stages, recognizing potential warning signs is crucial for timely intervention. As we commemorate Colorectal Cancer Awareness Month, let's deepen our understanding of this formidable disease and familiarize ourselves with its potential warning signs. Join us in spreading the word to raise awareness. Together, we can make a difference in the fight against colorectal cancer. #ColorectalCancerAwareness #EarlyDetection #SpreadAwareness #HealthAwareness #FightCRC

The 1st report from the Cancer Programme of the Genomes 100k project - Vivek Subbiah, MD #Cancer #Genomes100k #NationalHealthcareSystem #NHS #NatureMedicine #OncoDaily #Oncology #PrecisionMedicine

Did you know that up to 67% of prostate cancers are overdiagnosed [1]? Are you aware of the substantial underserved patient groups highly likely to be undertreated [2]? Why are focal (organ-preserving) therapies used in only a small portion of the population [3]? Let's discuss prostate cancer! Join us for a live event on January 11th, 2024, at 11 AM EST, where Dr. Mukesh Harisinghani, Dr. Paulo Leonardo Pfitzinger, and I will spend an hour talking about trends in personalization and patient management. Use this link, then click "Register": https://lnkd.in/etbPim2P Feel free to send your questions and suggestions upfront - will do my best to bring those up during the panel discussion. See you online on Thursday, January 11! #gehealthcare #prostatecancer #oncology References: 1. Overdiagnosis and Overtreatment of Prostate Cancer (Eur Urol. 2014 Jun; 65(6): 1046–1055) 2. Undertreatment of Prostate Cancer in Rural Residents (J Urol. 2020 Jan; 203(1): 108–114) 3. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? (Eur Urol. 2022 Jan;81(1):5-33)

As cancer programs consider where to invest resources to have the most significant impact, our Center for Advanced Oncology team identifies three areas of opportunity. October is #BreastCancerAwarenessMonth. #ECGMC #oncology

Some of the most practice-changing updates that affect cancer care today - Arif Kamal MD, MBA American Society of Clinical Oncology (ASCO) ABC11 WTVD-TV #AmericanCancerSociety #ClinicalOncology #ASCO24 #Cancer #CancerCare #HepatocellularCancer #Melanoma #OncoDaily #Oncology #PalliativeCare

The month of March is #ColorectalCancerAwarenessMonth and it is a great time to remind everyone 45 – 75 at average risk to get screened.*** At Polymedco, we offer a simple, clinically proven, cost-effective, non-invasive test. Read more here: *US Preventative Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238 **Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.000000000000122 ***Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ ajg.2017.174

Screening for colorectal cancer isn’t exactly something most people look forward to. It can be uncomfortable, invasive and time-consuming. No wonder 1 in 3 people who should get tested have never received any screening, according to the American Cancer Society. Yet this is essential care, as it can detect cancer when it is in its early stages and easier to treat. In fact, colorectal cancer is the second-most-common cause of cancer death in the United States. More than 53,000 Americans are expected to die of it this year alone. Here’s the good news: A new blood test might soon offer a more convenient way for people to get tested. Though it is not as effective at detecting cancers and precancerous polyps as colonoscopy, it can be a valuable tool for individuals who otherwise would put off testing. More in this week's Washington Post column: https://lnkd.in/etXWfHhn #coloncancer #cancerscreening #colonoscopy #cancerdetection #bloodtest #cancer #healthcare

March is National Colorectal Cancer Awareness Month. The Colorectal Cancer Alliance outlines two reasons why getting checked matters: 🟢 Screening can find the warning signs of colon and rectal cancer, letting doctors take action to prevent the disease. 🟢 Screening can also find colorectal cancer early, when treatment is most effective. Spread the word and take action. With the right tools and support, we can make a difference! https://lnkd.in/e-CzxNUa #ColorectalCancer